Pediatric Neurology · Stress-induced childhood-onset neurodegeneration with ataxia and seizures

Planning for the Future: Monitoring and Quality of Life

At a Glance

CONDSIAS can follow a stable or rapidly progressive course, so no single statistic predicts a child’s future. Individualized monitoring for breathing, heart rhythm, and seizures, together with pediatric palliative care, can help families manage symptoms and support quality of life.

Talking about the future when a child has CONDSIAS (Stress-induced childhood-onset neurodegeneration with ataxia and seizures) is difficult. Because this condition is ultra-rare, even the most experienced doctors are still learning about its long-term path ^[1]. While the diagnosis is heavy, understanding the patterns seen in other families can help you prepare and focus on what matters most: your child’s quality of life ^[2].

Understanding the Long-Term Outlook

Medical literature describes a wide range of outcomes for children with CONDSIAS. Some children experience a stable course for years, while others have a more rapid progression.

Survival Statistics: A 2024 review of 47 documented cases found that approximately 44.6% of those patients had passed away, with a median age at death of 7 years ^[3]. However, these numbers reflect only a small group of patients and include some of the most severe cases ever reported ^[1]. They suffer from publication bias, so they cannot predict an individual child’s lifespan.
Variable Paths: It is important to know that individual courses vary widely. Some patients have been reported alive and stable in their mid-20s, showing that a childhood diagnosis does not always mean a rapid decline ^[4]^[5].
Severe Complications: When deaths are reported, they are often linked to major “stress events,” such as sudden severe seizures (convulsions) following an infection, or respiratory failure ^[6]^[7].

Long-Term Monitoring: Watching for Changes

Because CONDSIAS can affect the brain, heart, and lungs, symptom-directed check-ups are used to catch and manage complications before they become emergencies ^[1]. There is no fixed surveillance schedule; testing should be individualized.

1. Respiratory Monitoring (The Lungs)

Progressive respiratory failure and central hypoventilation (where the brain “forgets” to tell the body to breathe deeply enough, especially during sleep) are reported risks in some patients ^[7]^[1].

Monitoring: Your team may recommend specialist-directed sleep studies (polysomnography) if symptoms suggest it, to check for pauses in breathing and ensure your child’s oxygen and carbon dioxide levels stay safe overnight ^[8].

2. Cardiac Monitoring (The Heart)

Some children with CONDSIAS develop autonomic dysfunction, which can cause irregular heart rhythms (arrhythmias) ^[9].

Monitoring: EKGs or heart monitors may be considered if your child has fainting spells or sudden weakness, to ensure the heart is beating correctly ^[10]^[9].

3. Neurological Monitoring (The Brain)

Because the condition is stepwise, your neurologist may use EEGs to monitor for “hidden” seizure activity and may consider an MRI to check for changes in brain volume (atrophy), weighing the risks of sedation ^[11]^[12].

The Role of Pediatric Palliative Care

One of the most misunderstood parts of rare disease care is palliative care. Many parents hear this term and think it is only for the end of life. In reality, pediatric palliative care is a specialized support system that should begin at the time of diagnosis, alongside active treatment ^[13]^[14].

The palliative team works alongside your neurologists and other specialists to:

Manage Symptoms: They are experts in treating pain, irritability, and sleep issues that can impact your child’s daily happiness ^[15].
Coordinate Care: They help you navigate the complex web of specialists and ensure everyone is following your family’s goals for your child’s care ^[16].
Provide Emotional Support: They offer a space for you to discuss difficult decisions and provide resources for siblings and parents ^[17]^[18].
Plan for the Future: They help you create “Advance Care Plans” so that if a crisis happens, the medical team knows exactly how you want your child to be treated ^[19]^[20].

Focusing on Quality of Life

While you cannot control the underlying genetics of CONDSIAS, you can have a massive impact on your child’s daily experience. Research shows that families who have a clear plan for symptom management and strong emotional support report a higher quality of life, even when facing a difficult diagnosis ^[21]^[22]. Every day that your child is comfortable, engaged, and supported is a success ^[23].

Common questions in this guide

What is the long-term outlook for a child with CONDSIAS?

CONDSIAS can follow different paths. Some children remain stable for years, while others experience more rapid progression. Published survival figures come from a small group and may overrepresent severe cases, so they cannot predict an individual child’s lifespan.

What monitoring tests might my child need for CONDSIAS?

There is no fixed monitoring schedule; testing is tailored to symptoms and care goals. Depending on concerns, clinicians may consider a sleep study for nighttime breathing, an EKG or heart monitor for possible rhythm problems, and an EEG or MRI for seizure activity or brain changes.

What signs of nighttime breathing problems should I watch for?

Central hypoventilation can cause breathing that is too shallow, especially during sleep. Long pauses in breathing, repeated waking, or other changes in sleep may prompt the care team to recommend a sleep study to check oxygen and carbon dioxide levels.

Does palliative care mean that treatment is ending?

No. Pediatric palliative care can begin at diagnosis and continue alongside active treatment. It can help manage pain, irritability, and sleep problems, coordinate specialists, support family members, and create an advance care plan.

How can our family support quality of life with CONDSIAS?

Families can focus on comfort, engagement, and activities that bring the child joy while working with the care team on symptom management. Emotional support and clear plans for possible crises can help the family make care decisions that reflect its priorities.

What can happen during a step in CONDSIAS progression?

A stepwise change may bring new symptoms or greater support needs. The care team can reassess breathing, heart, and neurological concerns and help adjust home support and goals for quality of life.

Get notified when new evidence is published on Childhood-onset stress-induced neurodegenerative ataxia-seizure syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References (23)

1
CONDSIAS, a Stress-Triggered Childhood Neurodegeneration: Four Novel ADPRS Variants and a Structured Review of the Reported Phenotype.
Comisi FF, Staccioli S, Travaglini L, et al.
Cerebellum (London, England) 2026; (25(6)).
PMID: 42986566
2
Amyotrophic lateral sclerosis: improving care with a multidisciplinary approach.
Hogden A, Foley G, Henderson RD, et al.
Journal of multidisciplinary healthcare 2017; (10()):205-215 doi:10.2147/JMDH.S134992.
PMID: 28579792
3
Delineation of ADPRHL2 Variants: Report of Two New Patients with Review of the Literature.
Öz Yıldız S, Yalnızoğlu D, Şimsek Kiper PÖ, et al.
Neuropediatrics 2024; (55(3)):156-165 doi:10.1055/s-0044-1779618.
PMID: 38365196
4
Phenotypic Diversity in Stress-induced Childhood-Onset Neurodegeneration with Variable Ataxia and Seizures: Novel Associations with Parkinsonism, Icthyosis and Cataract.
Nandana J, Fasaludeen A, Kumar AA, et al.
Cerebellum (London, England) 2025; (24(4)):112 doi:10.1007/s12311-025-01866-3.
PMID: 40493129
5
Episodic psychosis, ataxia, motor neuropathy with pyramidal signs (PAMP syndrome) caused by a novel mutation in ADPRHL2 (AHR3).
Durmus H, Mertoğlu E, Sticht H, et al.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2021; (42(9)):3871-3878 doi:10.1007/s10072-021-05100-w.
PMID: 33528672
6
Child-Onset Cerebellar Ataxia Caused by Two Compound Heterozygous Variants in ADPRS Gene: A Case Report.
Ma J, Qian Q, Yan S, et al.
Frontiers in genetics 2021; (12()):788702 doi:10.3389/fgene.2021.788702.
PMID: 35664652
7
An ADPRS variant disrupts ARH3 stability and subcellular localization in children with neurodegeneration and respiratory failure.
Bannister M, Bray S, Aggarwal A, et al.
HGG advances 2025; (6(1)):100386 doi:10.1016/j.xhgg.2024.100386.
PMID: 39580621
8
A novel variant in ADPRS disrupts ARH3 stability and subcellular localization in children with neurodegeneration and respiratory failure.
Bannister M, Bray S, Aggarwal A, et al.
bioRxiv : the preprint server for biology 2024; doi:10.1101/2024.06.14.597428.
PMID: 38915701
9
Case Report: Stress-Induced Childhood-Onset Neurodegeneration With Ataxia-Seizures Syndrome Caused by a Novel Compound Heterozygous Mutation in ADPRHL2.
Lu A, Dong C, Chen B, et al.
Frontiers in neurology 2022; (13()):807291 doi:10.3389/fneur.2022.807291.
PMID: 35222245
10
A PARP inhibitor, rucaparib, improves cardiac dysfunction in ADP-ribose-acceptor hydrolase 3 ( Arh3 ) deficiency.
Yamashita S, Bu X, Ishiwata-Endo H, et al.
bioRxiv : the preprint server for biology 2023; doi:10.1101/2023.02.07.527369.
PMID: 36945462
11
Novel imaging and clinical phenotypes of CONDSIAS disorder caused by a homozygous frameshift variant of ADPRHL2: a case report.
Aryan H, Razmara E, Farhud D, et al.
BMC neurology 2020; (20(1)):291 doi:10.1186/s12883-020-01873-3.
PMID: 32746785
12
Expanding the Spectrum of Stress-Induced Childhood-Onset Neurodegeneration with Variable Ataxia and Seizures (CONDSIAS).
Lindskov FO, Karlsson WK, Skovbølling SL, et al.
Cerebellum (London, England) 2024; (23(2)):861-871 doi:10.1007/s12311-023-01582-w.
PMID: 37392332
13
[Pediatric palliative care].
Mojžíšová M
Casopis lekaru ceskych 2018; (157(1)):37-40.
PMID: 29564906
14
Top Ten Tips Palliative Care Clinicians Should Know About Prognostication in Children.
Bergstraesser E, Thienprayoon R, Brook LA, et al.
Journal of palliative medicine 2021; (24(11)):1725-1731 doi:10.1089/jpm.2021.0439.
PMID: 34726519
15
A Dutch paediatric palliative care guideline: a systematic review and evidence-based recommendations for symptom treatment.
van Teunenbroek KC, Mulder RL, Ahout IML, et al.
BMC palliative care 2024; (23(1)):72 doi:10.1186/s12904-024-01367-w.
PMID: 38481215
16
What Constitutes High-Quality Paediatric Palliative Care? A Qualitative Exploration of the Perspectives of Children, Young People, and Parents.
Braybrook D, Coombes L, Scott HM, et al.
The patient 2025; (18(5)):539-561 doi:10.1007/s40271-025-00744-8.
PMID: 40415057
17
Supporting Parent Caregivers of Children with Life-Limiting Illness.
Koch KD, Jones BL
Children (Basel, Switzerland) 2018; (5(7)) doi:10.3390/children5070085.
PMID: 29949926
18
Facilitators and barriers for interdisciplinary collaboration in pediatric palliative care: A cross-sectional survey.
Kemna MM, Engel M, De Graaf E, et al.
Palliative medicine 2026; 2692163261482013 doi:10.1177/02692163261482013.
PMID: 42781905
19
A Dutch paediatric palliative care guideline: a systematic review and recommendations on advance care planning and shared decision-making.
van Teunenbroek KC, Mulder RL, van Heel DAM, et al.
BMC palliative care 2024; (23(1)):270 doi:10.1186/s12904-024-01568-3.
PMID: 39578755
20
The impact of specialized pediatric palliative care on advance care planning and healthcare utilization in children and young adults: a retrospective analysis of medical records of in-hospital deaths.
Kim CH, Lee J, Lee JW, Kim MS
BMC palliative care 2024; (23(1)):127 doi:10.1186/s12904-024-01448-w.
PMID: 38778335
21
Empowering Pediatric Palliative Homecare Patients and Caregivers with Symptom Management Plans.
Larrow A, Doshi A, Fisher E, et al.
Journal of pain and symptom management 2022; (64(4)):340-348 doi:10.1016/j.jpainsymman.2022.06.015.
PMID: 35835428
22
Community-based pediatric palliative care: a systematic review of structures, processes, and outcomes.
Acuña-Caicedo SA, González-Brossard AG, Pérez-González LE, et al.
Jornal de pediatria 2026; (102(2)):101510 doi:10.1016/j.jped.2026.101510.
PMID: 41633533
23
Paediatric palliative care improves patient outcomes and reduces healthcare costs: evaluation of a home-based program.
Chong PH, De Castro Molina JA, Teo K, Tan WS
BMC palliative care 2018; (17(1)):11 doi:10.1186/s12904-017-0267-z.
PMID: 29298714

This page is for informational purposes only and does not constitute medical advice about CONDSIAS. Your child’s neurologist and care team should tailor monitoring, symptom treatment, and advance care planning to your child.